Serum concentrations of interleukin-4 and interferon-gamma in relation to severe left ventricular dysfunction in patients with acute myocardial infarction undergoing percutaneous coronary intervention

Heart and Vessels

Volumn 26, Issue 4, 2011, Pages 399-407

  Szkodzinski, Janusz ^a   Hudzik, Bartosz ^a   Osuch, Marcin ^b   Romanowski, Wojciech ^a   Szygula Jurkiewicz, Bozena ^a   Polonski, Lech ^a   Zubelewicz Szkodzinska, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Cardiology Ward   (Poland)

Author keywords

Acute myocardial infarction; Interferon gamma; Interleukin 4; Severe LV dysfunction

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 4;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HEART VENTRICLE FAILURE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; STENT;

ADULT; ANGIOPLASTY, BALLOON, CORONARY; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-4; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLAND; PREDICTIVE VALUE OF TESTS; REGRESSION ANALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 79961245346     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0076-2     Document Type: Article

References (29)

1. JN Cohn R Ferrari N Sharpe 2000 Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling J Am Coll Cardiol 35 569 582 10716457 10.1016/S0735-1097(99)00630-0 1:STN:280: DC%2BD3c7nvFajsw%3D%3D (Pubitemid 30167013)
2. DL Mann JB Young 1994 Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines Chest 105 897 904 8131560 10.1378/chest.105.3.897 1:STN:280:DyaK2c7nvVShtw%3D%3D (Pubitemid 24088479)
3. L De Gennaro ND Brunetti A Cuculo PL Pellegrino M Di Biase 2008 Systemic inflammation in nonischemic dilated cardiomyopathy Heart Vessels 23 445 450 19037595 10.1007/s00380-008-1075-4
4. C Chrysohoou C Pitsavos J Barbetseas I Kotroyiannis S Brili K Vasiliadou L Papadimitriou C Stefanadis 2009 Chronic systemic inflammation accompanies impaired ventricular diastolic function, detected by Doppler imaging, in patients with newly diagnosed systolic heart failure (Hellenic Heart Failure Study) Heart Vessels 24 22 26 19165564 10.1007/s00380-008-1080-7
5. M Yamaoka S Yamaguchi M Okuyama H Tomoike 1999 Anti-inflammatory cytokine profile in human heart failure: behavior of interleukin-10 in association with tumor necrosis factor-alpha Jpn Circ J 63 951 956 10614840 10.1253/jcj.63.951 1:CAS:528:DC%2BD3cXhsVWktg%3D%3D (Pubitemid 30002060)
6. G Torre-Amione S Kapadia J Lee JB Durand RD Bies JB Young DL Mann 1996 Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart Circulation 93 704 711 8640999 1:STN:280:DyaK283jtFOqsw%3D%3D
7. T Tsutamoto T Hisanaga A Wada K Maeda M Ohnishi D Fukai N Mabuchi M Sawaki M Kinoshita 1998 Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure J Am Coll Cardiol 31 391 398 9462584 10.1016/S0735-1097(97)00494-4 1:STN:280:DyaK1c7it1CitA%3D%3D (Pubitemid 28153460)
8. K Kaur AK Sharma PK Singal 2006 Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction Am J Physiol Heart Circ Physiol 291 H106 H113 16461369 10.1152/ajpheart.01327.2005 1:CAS:528:DC%2BD28XntFGhsLo%3D
9. K Kaur S Dhingra J Slezak AK Sharma A Bajaj PK Singal 2009 Biology of TNF alpha and IL-10, and their imbalance in heart failure Heart Fail Rev 14 113 123 18712475 10.1007/s10741-008-9104-z 1:CAS:528:DC%2BD1MXjslWlsr0%3D
10. T Fukunaga H Soejima A Irie K Sugamura Y Oe T Tanaka S Kojima T Sakamoto M Yoshimura Y Nishimura H Ogawa 2007 Expression of interferon-gamma and interleukin-4 production in CD4+ T cells in patients with chronic heart failure Heart Vessels 22 178 183 17533522 10.1007/s00380-006-0955-8 (Pubitemid 46860672)
11. B Jug BG Salobir N Vene M Sebestjen M Sabovic I Keber 2009 Interleukin-6 is a stronger prognostic predictor than high-sensitive C-reactive protein in patients with chronic stable heart failure Heart Vessels 24 271 276 19626399 10.1007/s00380-008-1111-4
12. HC Yao SQ Liu K Yu M Zhou LX Wang 2009 Interleukin-2 enhances the cytotoxic activity of circulating natural killer cells in patients with chronic heart failure Heart Vessels 24 283 286 19626401 10.1007/s00380-008-1123-0
13. F Van de Werf J Bax A Betriu C Blomstrom-Lundqvist F Crea V Falk G Filippatos K Fox K Huber A Kastrati A Rosengren PG Steg M Tubaro F Verheugt F Weidinger M Weis ESC Committee for Practice Guidelines (CPG) A Vahanian J Camm R De Caterina V Dean K Dickstein G Filippatos C Funck-Brentano I Hellemans SD Kristensen K McGregor U Sechtem S Silber M Tendera P Widimsky JL Zamorano S Silber FV Aguirre N Al-Attar E Alegria F Andreotti W Benzer O Breithardt N Danchin C Di Mario D Dudek D Gulba S Halvorsen P Kaufmann R Kornowski GY Lip F Rutten 2008 Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the task force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology Eur Heart J 29 2909 2945 19004841 10.1093/eurheartj/ehn416
14. B Hudzik J Szkodzinski A Danikiewicz W Romanowski A Lekston L Polonski B Zubelewicz-Szkodzinska 2010 Serum interleukin-6 concentration predicts contrast-induced nephropathy in patients undergoing percutaneous coronary intervention Eur Cytokine Netw 21 129 135 20483707 1:CAS:528: DC%2BC3cXhtlSntr%2FE
15. RM Lang M Bierig RB Devereux FA Flachskampf E Foster PA Pellikka MH Picard MJ Roman J Seward JS Shanewise SD Solomon KT Spencer MS Sutton WJ Stewart Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines Standards Committee; European Association of Echocardiography 2005 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 1440 1463 16376782 10.1016/j.echo.2005.10.005 (Pubitemid 41821197)
16. DL Mann 1999 Mechanisms and models in heart failure: a combinatorial approach Circulation 100 999 1008 10468532 1:STN:280:DyaK1MzpvV2rtA%3D%3D (Pubitemid 29407182)
17. AA te Velde RJ Huijbens K Heije JE de Vries CG Figdor 1990 Interleukin-4 (IL-4) inhibits secretion of IL-1 beta, tumor necrosis factor alpha, and IL-6 by human monocytes Blood 76 1392 1397 2119829 1:CAS:528:DyaK3cXmtV2ksLk%3D (Pubitemid 20342757)
18. FJ Bijlsma J van Kuik E van Hoffen N de Jonge MG Tilanus FH Gmelig-Meyling RA de Weger 2002 Acute cardiac transplant rejection is associated with low frequencies of interleukin-4 producing helper T-lymphocytes rather than with interleukin-4 promoter or splice variants Hum Immunol 63 317 323 12039414 10.1016/S0198-8859(02)00370-1 1:CAS:528:DC%2BD38XitlGhurw%3D (Pubitemid 34303703)
19. E Paffen P Medina MC de Visser A van Wijngaarden E Zorio A Estellés FR Rosendaal F Espana RM Bertina CJ Doggen 2008 The -589C> T polymorphism in the interleukin-4 gene (IL-4) is associated with a reduced risk of myocardial infarction in young individuals J Thromb Haemost 6 1633 1638 18662263 10.1111/j.1538-7836.2008.03096.x 1:CAS:528:DC%2BD1cXhtlaitLrF
20. E Mostafa Mtairag S Chollet-Martin M Oudghiri N Laquay MP Jacob JB Michel LJ Feldman 2001 Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion Cardiovasc Res 49 882 890 11230988 10.1016/S0008-6363(00)00287-X 1:CAS:528:DC%2BD3MXhsVOiu78%3D (Pubitemid 32178392)
21. SM Opal VA DePalo 2000 Anti-inflammatory cytokines Chest 117 1162 1172 10767254 10.1378/chest.117.4.1162 1:CAS:528:DC%2BD3cXjtFahsb0%3D (Pubitemid 30228378)
22. L Karpinski R Plaksej W Kosmala M Witkowska 2008 Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty Kardiol Pol 66 1279 1285 19169974
23. A Yndestad AM Holm F Muller S Simonsen SS Froland L Gullestad P Aukrust 2003 Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure Cardiovasc Res 60 141 146 14522416 10.1016/S0008-6363(03)00362-6 1:CAS:528:DC%2BD3sXns12ku7Y%3D (Pubitemid 38373485)
24. Y Morino K Hara H Ushikoshi K Tanabe Y Kuroda T Noguchi S Ayabe H Hara Y Yanbe K Kozuma Y Ikari F Saeki T Tamura 2000 γ-Interferon-induced cardiomyopathy during treatment of renal cell carcinoma: a case report J Cardiol 36 49 57 10929266 1:STN:280:DC%2BD3cvotlCksQ%3D%3D (Pubitemid 30603027)
25. K Reifenberg HA Lehr M Torzewski G Steige E Wiese I Küpper C Becker S Ott P Nusser K Yamamura G Rechtsteiner T Warger A Pautz H Kleinert A Schmidt B Pieske P Wenzel T Münzel J Löhler 2007 Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice Am J Pathol 171 463 472 17556594 10.2353/ajpath.2007.060906 1:CAS:528:DC%2BD2sXpsFaiurw%3D (Pubitemid 47344679)
26. M Sartori S Andorno G La Terra G Pozzoli M Rudoni GM Sacchetti E Inglese M Aglietta 1995 Assessment of interferon cardiotoxicity with quantitative radionuclide angiocardiography Eur J Clin Invest 25 68 70 7705390 10.1111/j.1365-2362.1995.tb01528.x 1:STN:280:DyaK2M3itVCjtA%3D%3D
27. G Sardella L De Luca V Francavilla D Accapezzato A Di Roma O Gianoglio R Colantonio M Mancone F Fedele M Paroli 2007 Effect of coronary percutaneous revascularization on interferon-gamma and interleukin-10 producing CD4+ T cells during acute myocardial infarction Int J Immunopathol Pharmacol 20 791 799 18179752 1:CAS:528:DC%2BD1cXht1ahsbw%3D
28. ME Hands V Antico PL Thompson J Hung JS Robinson BL Lloyd 1987 Differences in left ventricular function between anterior and inferior myocardial infarction of equivalent enzymatic size Int J Cardiol 17 155 167 3679599 10.1016/0167-5273(87)90127-6 1:STN:280:DyaL1c%2FlslOhtQ%3D%3D
29. RD Rakhit C Seiler K Wustmann S Zbinden S Windecker B Meier FR Eberli 2005 Tumour necrosis factor-alpha and interleukin-6 release during primary percutaneous coronary intervention for acute myocardial infarction is related to coronary collateral flow Coron Artery Dis 16 147 152 15818083 10.1097/00019501-200505000-00003 (Pubitemid 40586196)